-
Louis's Most Popular
Search Results
240 results for idix
Biotech Movers: Dendreon Pops, ArQule Drops
An analyst upgrade on DNDN lifted the shares 21% last Friday, but mid-stage trial failure of a colorectal drug sank ARQL 11% the same day.
Biotech Movers: Acadia Rockets on Trial News
Acadia Pharmaceuticals leads the way with a week of eye-popping gains. Plus: Why Exelixis and Supernus took tough tumbles.
BAC, Financials Lead Markets to Gains — Tuesday’s IP Market Recap
Stocks closed at a six-month high. Even Kodak saw a bounce.
Merck Is Shopping for Smarts In Hep C
The pharma giant says it’s determined to be the leader in treatments for the disease — a market that is expected to hit $20 billion…
Hepatitis C Drug Progress Puts Several Companies on Acquisition Watch
With their hepatitis C drugs showing promise in trials, these drug makers have become attractive targets for bigger pharma players.
Idenix and Achillion Jump on Takeover Talk
Their hepatitis C drugs could be lures for Big Pharma after a rival gets a juicy offer from Bristol-Myers Squibb.
Gilead’s Giant Gamble in Buying Pharmasset
The $11B price tag raises the stakes big-time, and critics say Gilead is overpaying to get Pharmasset’s promising hepatitis C treatment.
4 Ways to Play the Boom in Biotech Stocks
Whether you love risk or hate it, there’s a way to invest in red-hot biotech stocks. Here are four options for investors of all different…
Top 10 Dow Dividend Stocks for June
Looking for yield as we begin the second half? Look no further than these top 10 Dow dividend stocks.
Ideanomics Is the Jackson Pollock of Clean Energy
Ideanomics is throwing together a hodgepodge of clean energy and fintech bets. That doesn’t make IDEX stock a buy. Here’s why.
Quant Score Make IDEXX Laboratories (IDXX) a Buy
The current recommendation of Buy for IDEXX Laboratories Inc (NASDAQ:IDXX) has been derived by using the Portfolio Grader stock evaluator of Louis Navellier, which incorporates…
5 Great European Stock Funds
Mutual funds with exposure to Europe give investors exposure to cheap, high-quality stocks as the region emerges from recession.
Ideanomics Offers Exposure to Multiple Sectors of Interest
Could IDEX stock turn out to be a long-term compounder? It’s possible as Ideanomics is involved with some interesting niche sectors.
Try a Different Approach to EV Investing With Ideanomics Stock
IDEX stock doesn’t fit the mold when it comes to electric vehicle investments. But that’s fine as it could be next year’s breakout EV star.
IDEX Stock Alert: Ideanomics Announces 1-for-125 Reverse Split
Ideanomics (IDEX) stock is down 25% today after the electric vehicle (EV) maker announced an upcoming 1-for-125 reverse stock split.
When and How to Buy Ideanomics Stock
Trust is being earned these days in IDEX stock, but a smarter idea for investors is to hedge that optimism with a collar strategy.
Invest in China’s Electric Vehicle Expansion With Ideanomics
You might not be familiar with IDEX stock, but you can participate in the red-hot international EV market through a position in IDEX shares.
Idexx Laboratories, Inc. (IDXX) Stock Is for the Birds … And Dogs and Cats
With U.S. spending on our furry friends continuing to climb, Idexx Laboratories is well positioned for long-term growth and IDXX stock is worth a look.
Why IDEX Stock Is Headed for Zero
As was the case last fall, when it was trading for more than five times what it trades for today, avoid IDEX stock at all…
Don’t Count on a Comeback for IDEX Stock
This is a situation that stands to go from bad to worse, with little to signal big improvements are just around the corner. The best…
2 – 10 of 240 results
